CY1131A - Pharmaceutical compositions for use in the suppression of gastric reflux - Google Patents
Pharmaceutical compositions for use in the suppression of gastric refluxInfo
- Publication number
- CY1131A CY1131A CY1131A CY113177A CY1131A CY 1131 A CY1131 A CY 1131A CY 1131 A CY1131 A CY 1131A CY 113177 A CY113177 A CY 113177A CY 1131 A CY1131 A CY 1131A
- Authority
- CY
- Cyprus
- Prior art keywords
- suppression
- pharmaceutical compositions
- gastric reflux
- gastric
- reflux
- Prior art date
Links
- 230000002496 gastric effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000010992 reflux Methods 0.000 title 1
- 230000001629 suppression Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB46543/76A GB1524740A (en) | 1976-11-09 | 1976-11-09 | Pharmaceutical compositions for use in the suppression of gastric reflux |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1131A true CY1131A (en) | 1982-05-07 |
Family
ID=10441659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY1131A CY1131A (en) | 1976-11-09 | 1977-04-05 | Pharmaceutical compositions for use in the suppression of gastric reflux |
Country Status (15)
Country | Link |
---|---|
US (1) | US4140760A (nl) |
JP (1) | JPS5359016A (nl) |
AU (1) | AU509823B2 (nl) |
BE (1) | BE858003A (nl) |
CA (1) | CA1083964A (nl) |
CY (1) | CY1131A (nl) |
DE (1) | DE2738014A1 (nl) |
FR (1) | FR2369843A1 (nl) |
GB (1) | GB1524740A (nl) |
HK (1) | HK59681A (nl) |
IE (1) | IE45655B1 (nl) |
KE (1) | KE3175A (nl) |
NL (1) | NL188892C (nl) |
NZ (1) | NZ184931A (nl) |
ZA (1) | ZA774920B (nl) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3228231A1 (de) * | 1982-07-28 | 1984-02-02 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München | Arzneimittel, calciummischsalze von polymeren, anionischen carbonsaeuren und/oder schwefelsaeureestern, verfahren zu ihrer herstellung und ihre verwendung |
GB8323624D0 (en) * | 1983-09-02 | 1983-10-05 | Reckitt & Colmann Prod Ltd | Medicinal compositions |
US4613497A (en) * | 1984-02-29 | 1986-09-23 | Health Products Development, Inc. | Dry, water-foamable pharmaceutical compositions |
JPH0764737B2 (ja) * | 1984-04-19 | 1995-07-12 | ローヌ−プーラン ローラー インターナショナル (ホウルディングス) インコーポレイテッド | 制酸組成物 |
US4869902A (en) * | 1984-04-19 | 1989-09-26 | Rorer Pharmaceutical Corporation | Antacid composition |
NZ215069A (en) * | 1985-03-01 | 1988-06-30 | Reckitt & Colmann Prod Ltd | Pharmaceutical composition with histamine h 2 -receptor antagonist |
US5254591A (en) * | 1986-01-03 | 1993-10-19 | The University Of Melbourne | Pharmaceutical composition for treating gastroesophageal reflux |
AU594424B2 (en) * | 1986-01-03 | 1990-03-08 | University Of Melbourne, The | Gastro-oesophageal reflux composition |
US4744986A (en) * | 1986-03-07 | 1988-05-17 | Rorer Pharmaceutical Corporation | Process for the preparation of a viscosity-stable antacid composition |
US5112813A (en) * | 1986-03-07 | 1992-05-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Process for the preparation of a viscosity-stable antacid composition |
US5002777A (en) * | 1986-06-24 | 1991-03-26 | Norcliff Thayer Inc. | Encapsulated antacid |
DK179687D0 (da) * | 1987-04-08 | 1987-04-08 | Farma Food As | Praeparat |
GB2222772B (en) * | 1988-09-20 | 1992-05-13 | Glaxo Group Ltd | Pharmaceutical compositions |
US5460803A (en) * | 1989-05-24 | 1995-10-24 | American Dental Association Health Foundation | Methods and compositions for mineralizing and fluoridating calcified tissues |
US5827247A (en) * | 1991-08-20 | 1998-10-27 | Bioderm | External incontinence device and vapor-absorptive adhesive compositions |
US5360793A (en) * | 1993-05-24 | 1994-11-01 | Sterling Winthrop Inc. | Rafting antacid formulation |
US5427768A (en) * | 1993-06-23 | 1995-06-27 | American Dental Association Health Foundation | Carbonated solutions for treating, mineralizing and fluoridating calcified tissues and methods for their use |
US5455050A (en) * | 1993-11-12 | 1995-10-03 | Mcneil-Ppc, Inc. | Aqueous antacids with calcium carbonate and magnesium salt |
GB9504599D0 (en) * | 1995-03-03 | 1995-04-26 | Reckitt & Colmann Prod Ltd | Improvements in or relating to organic compositions |
US6099871A (en) * | 1995-06-01 | 2000-08-08 | Bristol-Myers Squibb Company | Anti-regurgitation infant formula |
GB9708772D0 (en) * | 1997-04-30 | 1997-06-25 | Reckitt & Colmann Prod Ltd | Organic compositions |
WO1998048814A1 (en) * | 1997-04-30 | 1998-11-05 | Reckitt & Colman Products Limited | Pourable alginate compositions |
EP1067943A4 (en) * | 1998-03-11 | 2008-09-24 | Smithkline Beecham Corp | PROCESS FOR PRODUCING AQUEOUS SUSPENSION OF CALCIUM CARBONATE |
US20030220258A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
GB9812426D0 (en) * | 1998-06-10 | 1998-08-05 | Reckitt & Colmann Prod Ltd | Improvements in or relating to organic compositions |
GB0005743D0 (en) * | 2000-03-10 | 2000-05-03 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions including alginates |
US7358330B2 (en) * | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
GB0012094D0 (en) * | 2000-05-19 | 2000-07-12 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
US20030165606A1 (en) * | 2001-07-18 | 2003-09-04 | Lasekan John B. | Anti-regurgitation formula and uses thereof |
SE0103613D0 (sv) * | 2001-10-30 | 2001-10-30 | Astrazeneca Ab | Novel formulation |
SE0103722D0 (sv) * | 2001-10-30 | 2001-10-30 | Astrazeneca Ab | Novel formulation |
US6989166B2 (en) * | 2001-12-20 | 2006-01-24 | N.V. Nutricia | Soft drink replacer |
US6779530B2 (en) | 2002-01-23 | 2004-08-24 | Schweitzer-Mauduit International, Inc. | Smoking articles with reduced ignition proclivity characteristics |
GB2384986B (en) * | 2002-02-12 | 2004-01-07 | Reckitt Benckiser Healthcare | Compositions for the treatment of disorders of the upper gastrointestinal tract |
TR200300510A2 (tr) * | 2003-04-18 | 2004-11-22 | Sanovel �La� Sanay� Ve T�Caret A.�. | Dağılan alendronat mikropartikül formülasyonu |
US7198653B2 (en) * | 2003-07-31 | 2007-04-03 | Delavau Llc | Calcium carbonate granulation |
DE102004063612B4 (de) * | 2004-01-02 | 2017-01-12 | Manfred Helms | Gelartiges Basenpräparat sowie Verwendung eines Gelbildners zu dessen Herstellung |
US20060073202A1 (en) * | 2004-10-05 | 2006-04-06 | Rocca Jose G | Dual component medicament delivery system |
US8151806B2 (en) * | 2005-02-07 | 2012-04-10 | Schweitzer-Mauduit International, Inc. | Smoking articles having reduced analyte levels and process for making same |
GB0515492D0 (en) * | 2005-07-28 | 2005-08-31 | Reckitt Benckiser Healthcare | Improvements in or relating to compositions,articles and methods |
SE530605C2 (sv) * | 2005-09-29 | 2008-07-15 | Barbara Nelson | Läkemedel innehållande ett syrahämmande medel, avseende att användas för att motverka och bota luftvägssjukdomar |
WO2007039294A2 (en) * | 2005-10-05 | 2007-04-12 | Fmc Biopolymer As | Gelling compositions and methods |
EP1864692A1 (en) * | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Use of peptides for the control of radiation injury |
IL175338A0 (en) * | 2006-05-01 | 2006-09-05 | Biota Ltd | Orally administrable films and preparation thereof |
US8869805B2 (en) * | 2006-06-01 | 2014-10-28 | Schweitzer-Mauduit International, Inc. | Free air burning smoking articles with reduced ignition proclivity characteristics |
US9138414B1 (en) | 2006-09-15 | 2015-09-22 | Delavau Llc | Calcium supplement having enhanced absorption |
US20090148530A1 (en) | 2007-12-08 | 2009-06-11 | Jamie Koufman | Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin |
JP2013525313A (ja) * | 2010-04-23 | 2013-06-20 | エス−バイオテック ホールディング エーピーエス | 胃酸を中和する固形医薬組成物 |
EP2806880B2 (en) | 2012-01-27 | 2020-04-22 | Institute of Bioorganic Chemistry | Pharmaceutical composition as a substance for antireflux antacid drug |
ITRM20120041A1 (it) | 2012-02-08 | 2013-08-09 | Dicofarm Spa | "prodotto a base di glucomannano e chitosano utile per il trattamento del reflusso gastroesofageo" |
RU2479318C1 (ru) * | 2012-03-29 | 2013-04-20 | Общество с ограниченной ответственностью "ВИТТА" (ООО "ВИТТА") | Способ получения лекарственных и биологически активных средств |
KR101417287B1 (ko) * | 2012-06-15 | 2014-07-08 | 동아제약 주식회사 | 신규한 위식도역류질환 치료용 조성물 |
KR102211670B1 (ko) * | 2012-07-19 | 2021-02-02 | 리립사, 인크. | 가교결합된 양이온-결합 폴리머를 포함하는 조성물 |
JP5939943B2 (ja) | 2012-09-14 | 2016-06-22 | ヤンマー株式会社 | エンジン装置 |
EP2906057A1 (en) | 2012-10-11 | 2015-08-19 | Schweitzer-Mauduit International, Inc. | Wrapper having reduced ignition proclivity characteristics |
KR102303835B1 (ko) * | 2014-01-08 | 2021-09-16 | 영진약품 주식회사 | 수성의 유동성 액체 조성물 및 이의 제조방법 |
ITUB20159732A1 (it) * | 2015-12-22 | 2017-06-22 | S I I T S R L Servizio Int Imballaggi Termosaldanti | Composizioni orali per il trattamento della malattia da reflusso gastroesofageo |
FR3071728B1 (fr) | 2017-09-29 | 2019-09-27 | Laboratoires Arkopharma | Composition adaptee pour former un radeau gastrique gelifie |
CA3092619A1 (en) | 2018-03-02 | 2019-09-06 | Pharagen Llc | Formulations for treating acid reflux comprising sodium alginate |
CN114191307A (zh) | 2020-09-17 | 2022-03-18 | 上海汉都医药科技有限公司 | 一种口腔滞留装置及其制备方法 |
EP3797818B1 (en) | 2018-05-23 | 2023-01-18 | Shanghai WD Pharmaceutical Co., Ltd | Controlled-release system of active pharmaceutical ingredient and preparation method therefor |
US11911513B2 (en) | 2018-05-23 | 2024-02-27 | Shanghai Wd Pharmaceutical Co., Ltd | Controlled-release system of active pharmaceutical ingredient and preparation method therefor |
CN115777783A (zh) * | 2022-07-04 | 2023-03-14 | 浙江上方生物科技有限公司 | 一种防止胃食管倒流的健康饮料及其制备方法 |
WO2024030933A1 (en) | 2022-08-02 | 2024-02-08 | Nutrition & Biosciences Usa 1, Llc | Novel alginate and cellulose derivative based composition of the liquid anti-reflux formulation |
WO2024030936A1 (en) * | 2022-08-02 | 2024-02-08 | Nutrition & Biosciences Usa 1, Llc | Modified-release alginate-based composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3330729A (en) * | 1963-10-04 | 1967-07-11 | Goodrich Co B F | Sustained release tablet containing medicament admixed in a waterinsoluble acrylic acid cross-linked polymer and selected basic magnesium or calcium diluent |
US3326755A (en) * | 1965-06-15 | 1967-06-20 | Warner Lambert Pharmaceutical | Alginate containing antacid compositions |
US3767794A (en) * | 1969-11-21 | 1973-10-23 | Richardson Merrell Inc | Antifoam preparations and method of preparing same |
JPS5176415A (en) * | 1974-12-26 | 1976-07-02 | Riken Vitamin Oil Co Ltd | Choyoseiseizaino seizohoho |
-
1976
- 1976-11-09 GB GB46543/76A patent/GB1524740A/en not_active Expired
-
1977
- 1977-04-01 US US05/783,957 patent/US4140760A/en not_active Expired - Lifetime
- 1977-04-05 CY CY1131A patent/CY1131A/xx unknown
- 1977-08-10 IE IE1672/77A patent/IE45655B1/en not_active IP Right Cessation
- 1977-08-15 ZA ZA00774920A patent/ZA774920B/xx unknown
- 1977-08-16 NZ NZ184931A patent/NZ184931A/xx unknown
- 1977-08-16 CA CA284,945A patent/CA1083964A/en not_active Expired
- 1977-08-22 BE BE180345A patent/BE858003A/xx not_active IP Right Cessation
- 1977-08-23 DE DE19772738014 patent/DE2738014A1/de active Granted
- 1977-08-23 FR FR7725735A patent/FR2369843A1/fr active Granted
- 1977-08-23 JP JP10099677A patent/JPS5359016A/ja active Granted
- 1977-08-23 NL NLAANVRAGE7709307,A patent/NL188892C/nl not_active IP Right Cessation
- 1977-08-29 AU AU28306/77A patent/AU509823B2/en not_active Expired
-
1981
- 1981-11-24 KE KE3175A patent/KE3175A/xx unknown
- 1981-12-03 HK HK596/81A patent/HK59681A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JPS5359016A (en) | 1978-05-27 |
ZA774920B (en) | 1979-03-28 |
NL188892C (nl) | 1992-11-02 |
DE2738014C2 (nl) | 1988-08-18 |
NL7709307A (nl) | 1978-05-11 |
JPS646172B2 (nl) | 1989-02-02 |
FR2369843B1 (nl) | 1980-12-26 |
NZ184931A (en) | 1979-06-08 |
BE858003A (fr) | 1977-12-16 |
AU509823B2 (en) | 1980-05-29 |
HK59681A (en) | 1981-12-11 |
KE3175A (en) | 1982-01-08 |
GB1524740A (en) | 1978-09-13 |
IE45655B1 (en) | 1982-10-20 |
FR2369843A1 (fr) | 1978-06-02 |
CA1083964A (en) | 1980-08-19 |
IE45655L (en) | 1978-05-09 |
AU2830677A (en) | 1979-03-08 |
DE2738014A1 (de) | 1978-05-18 |
US4140760A (en) | 1979-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1131A (en) | Pharmaceutical compositions for use in the suppression of gastric reflux | |
ZA771090B (en) | Pharmaceutical compositions | |
PT66622A (en) | Pharmaceutical compositions | |
SG61784G (en) | Nasal pharmaceutical compositions | |
PT67009B (en) | Processes for the preparation of pharmaceutical compositions | |
AU3111677A (en) | Pharmaceutical compositions | |
ZA771003B (en) | Pharmaceutical compositions containing pyrethrinoides | |
NZ185986A (en) | 2-oxa-bicyclic prostag-landins and pharmaceutical compositions | |
NZ183551A (en) | Aminochromanols and pharmaceutical compositions containingthem | |
NZ185358A (en) | Spiro-hydantoins and pharmaceutical compositions | |
ZA763917B (en) | Pharmaceutical compositions and compounds | |
NZ183134A (en) | I-i-(3-aryloxy-2-hydroxypropyl)-4-piperidyl-3-aryl-imid-azolidin or hexahydropyrimidin-2-ones; and pharmaceutical compositions | |
NZ184428A (en) | N-acyl-l-alanyl-aminoacyl-amides untermediates and pharmaceutical compositions | |
AU3152677A (en) | Pharmaceutical composition | |
NZ186147A (en) | Sterolin pharmaceutical compositions | |
NZ184539A (en) | 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine pharmaceutical compositions | |
NZ184912A (en) | 2-phenylamino-imidazolines and pharmaceutical compositions | |
AU2609277A (en) | Pharmaceutical compositions | |
AU2649977A (en) | Pharmaceutical composition | |
NZ183549A (en) | Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions | |
NZ184808A (en) | Heterocyclic compounds and pharmaceutical compositions | |
IL52103A0 (en) | Pharmaceutical compositions containing naphthopyrane derivvatives | |
ZA772612B (en) | Pharmaceutical compositions | |
AU2574877A (en) | Pharmaceutical compositions | |
GB1547206A (en) | Pharmaceutical compositions |